3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
NET
1
Gastrointestinal
1
Endocrine
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms, Unknown Primary
1
Gastrointestinal Stromal Tumors
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Colonoscopy
44
Standard of Care
29
Early Intervention, Educational
23
Methods
22
Blood Specimen Collection
21
Exercise
20
Educational Status
19
Interviews as Topic
13
Surveys and Questionnaires
12
Practice Guidelines as Topic
12
Patient Navigation
12
Counseling
12
Endoscopic Mucosal Resection
10
Drug Therapy
10
Oxaliplatin
9
Irinotecan
8
Fluorouracil
8
Surgical Procedures, Operative
7
Preoperative Exercise
7
Lidocaine
7
Bevacizumab
7
Therapeutics
6
Resistance Training
6
Occult Blood
6
Narrow Band Imaging
6
Mass Screening
6
Leucovorin
6
Diet
6
Decision Support Techniques
6
Control Groups
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Colorectal Neoplasms
×
Poly(ADP-ribose) Polymerase Inhibitors
×
Clear all
NCT04584008
2024-10-15
VISIONARY
Peking University
Phase NA
Active not recruiting
600 enrolled